Akeso Future Growth
Future criteria checks 2/6
Akeso is forecast to grow earnings and revenue by 10.3% and 18.4% per annum respectively. EPS is expected to grow by 0.07% per annum. Return on equity is forecast to be 19.8% in 3 years.
Key information
10.3%
Earnings growth rate
0.07%
EPS growth rate
Biotechs earnings growth | 36.7% |
Revenue growth rate | 18.4% |
Future return on equity | 19.8% |
Analyst coverage | Good |
Last updated | 21 Jun 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 6,030 | 1,272 | 1,204 | 1,695 | 18 |
12/31/2025 | 4,134 | 227 | -95 | 291 | 19 |
12/31/2024 | 2,623 | -449 | -646 | -500 | 19 |
12/31/2023 | 4,526 | 2,028 | 1,588 | 2,468 | N/A |
9/30/2023 | 4,439 | 2,008 | 1,459 | 2,340 | N/A |
6/30/2023 | 4,351 | 1,987 | 1,330 | 2,212 | N/A |
3/31/2023 | 2,595 | 409 | -356 | 486 | N/A |
12/31/2022 | 838 | -1,168 | -2,043 | -1,240 | N/A |
9/30/2022 | 549 | -1,224 | -1,997 | -1,238 | N/A |
6/30/2022 | 260 | -1,280 | -1,952 | -1,235 | N/A |
3/31/2022 | 243 | -1,178 | -1,835 | -1,118 | N/A |
12/31/2021 | 226 | -1,075 | -1,717 | -1,001 | N/A |
9/30/2021 | 177 | -1,002 | -1,525 | -882 | N/A |
6/30/2021 | 129 | -929 | -1,333 | -762 | N/A |
3/31/2021 | 64 | -983 | -1,200 | -690 | N/A |
12/31/2020 | N/A | -1,036 | -1,066 | -618 | N/A |
9/30/2020 | 35 | -870 | -814 | -443 | N/A |
6/30/2020 | 71 | -703 | -562 | -267 | N/A |
3/31/2020 | 71 | -492 | -459 | -243 | N/A |
12/31/2019 | 71 | -282 | -356 | -220 | N/A |
12/31/2018 | 3 | -142 | -198 | -123 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 9926's forecast earnings growth (10.3% per year) is above the savings rate (2.2%).
Earnings vs Market: 9926's earnings (10.3% per year) are forecast to grow slower than the Hong Kong market (11.6% per year).
High Growth Earnings: 9926's earnings are forecast to grow, but not significantly.
Revenue vs Market: 9926's revenue (18.4% per year) is forecast to grow faster than the Hong Kong market (7.9% per year).
High Growth Revenue: 9926's revenue (18.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 9926's Return on Equity is forecast to be low in 3 years time (19.8%).